ClosedResearch announcementOpportunity HT942526PRCRPIPA

DoW, Peer Reviewed Cancer, Impact Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW, Peer Reviewed Cancer, Impact Award is a closed federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). The application deadline was October 5, 2026. Total estimated funding is $45M across about 30 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

May 6, 2026Posted
Oct 5, 2026Application deadline
Nov 4, 2026Archivednext date

Posted: May 6, 2026
Close date: Oct 5, 2026
Archive date: Nov 4, 2026
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $45,000,000
Implied average award: $1,500,000 calculated
Expected awards: 30
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary

Typical awards for this program (SAM.gov listing for ALN 12.420, not this notice): This Assistance Listing supports approximately 30 or more programs each year. Overall, awards are expected to range from $100,000 to $20M (consortium) depending on the funding priorities, anticipated number of awards, and project activity/scope within each program for an award period, on average, of 3 to 4 years. The maximum award amount, if any, is specified in each Program Announcement or Broad Agency Announcement.

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

Unrestricted (any entity type)

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Impact Award supports mature research that will have a near-term impact on clinical cancer care in one of the congressionally directed FY26 PRCRP Topic Areas. Applicants must consider how the research project will lead to the advancement of knowledge in cancer research, patient care and/or treatment options in the Military Health System (MHS).

Distinctive Features:

• Applications must include preliminary data to support feasibility of the study.

• Projects must have strong potential to result in a near-term impact in cancer.

• The funding mechanism allows clinical trials.

• This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. Only the Initiating PI will submit a pre-application, but both PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. Be advised, both applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

FY26 PRCRP IPA Program AnnouncementFull Announcement · HT942526PRCRPIPA_GG.pdfPDF · 822 KB

Assistance Listing

What is an ALN?

12.420Military Medical Research and DevelopmentProgram →

Reported obligations under ALN 12.420

Historical data · not a prediction

FY24

$1.48B

FY25

$1.2B

FY26

— est.

Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Abigail Strock Contract Specialist
help@eBRAP.org
3016192342

Quick answers

Who is eligible to apply for “DoW, Peer Reviewed Cancer, Impact Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW, Peer Reviewed Cancer, Impact Award”?

Per the notice, total estimated program funding is $45,000,000 and the agency expects to make about 30 awards.

How do I apply for “DoW, Peer Reviewed Cancer, Impact Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526PRCRPIPA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

Closes in 13 daysResearchALN 12.420